FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

APOLLOHOSP

1,376
+13.45 (0.99%)
Updated 03:29 03/07 IST

APOLLOHOSP Buy or Sell - FrontPage Forums

1 Users have submitted 1 trade ideas of Rs. 833,625 for APOLLOHOSP
Disclaimer
100% Bullish
0% Bearish

APOLLOHOSP Buy or Sell - Brokerage Reports

No. of reports in last year
1
No. of analysts
1
Average Consensus Forecast
1800
Consensus Potential
24.30%
See APOLLOHOSP Share Price Targets >>

APOLLOHOSP Ratings

Long term APOLLOHOSP rating by FrontPage users
5/5 (3 Ratings)
Find answers to all your questions on live APOLLOHOSP message board: Is APOLLOHOSP buy or sell? Should I buy APOLLOHOSP shares? Why are APOLLOHOSP shares falling? Should I invest in APOLLOHOSP stock?

  1. Home
  2. APOLLOHOSP Forum

APOLLOHOSP Share Price Discussion


Futures & Options educational trades for the week 6.7.20 to 10.7.20*
(My trade rules apply).
#stockmarket
Apollohosp* cmp 1380.55 buy upto 1321.00 stop 1307.00 target 1461.00+
Like
Reply
N
Reputation: 3,821 • Jul 3 10:06 AM
Apollo Hospitals Group's Proton Cancer Centre gets JCI accreditation
The JCI accreditation is the gold standard given to organisations that practice and follow the highest international standards in order to provide world-class patient care and safety, the statement said.
The Economic Times
Like
Reply

Today's paid performance
Buy at 342
Target hit
High 354😍😍😍😍😍
1500*12=18000/-
22300ce
Buy
315
Target
335
Hit
20*100=2000/-
....
Gbpinr
=Buy
93.3400
Target open
High 93.7800
More than 7000/- profit.
...
Above 891
898
High
650*7=4550/...
Read more...
1
Reply
P
Reputation: 87,351 • Jul 3 6:05 AM

Type
Sell
Instrument
APOLLOHOSP JUL20 FUT
Entry Price
₹1,397.85
Price@Trade
₹1,397.85
Target Price
₹1,380
Stop Price
₹1,405
Valid Till
Jul 3, 2020 3:20 AM
Margin
₹402,244.75 approx for 1000 Qty
Status
Exited
Exit Price
₹1,392
Net P&L
+₹5,850 (+1.45%)
Like
Reply (1)
Latest replies
ProTrader @ProTraderIndia
Jul 3 6:20 AM

Update
Exited
Exit Price
₹1,392
Net P&L
+₹5,850 (+1.45%)
Trade here in APOLLOHOSP
1402.10 500*2=1000/-🤩🤩🤩🤩💴💴💴💴💵💵💵🏆🏆🏆🏆 #APOLLOHOSP

1404.90
Now risk is yours profit is yours
It has given profit for paid subscription
Now decision is yours
🏆🏆🏆🏆💵💵💵💴💴💴💴🏆🏆🏆 #APOLLOHOSP
Like
Reply
Trade here in APOLLOHOSP
1402.10 500*2=1000/-🤩🤩🤩🤩💴💴💴💴💵💵💵🏆🏆🏆🏆 #APOLLOHOSP
1
Reply (10)
Latest replies

Level has been much before
And safer booked their
3 points
Lot size 500
Total =1500/-
🤩🤩😍😍
Prerana @Prerana2019
Jul 3 4:14 AM

thanks sir
Prerana @Prerana2019
Jul 3 4:16 AM

booked 2000/- profit see you in paid on monday.
Trade here @tejveertradingzone
Yesterday 1:25 AM
Trade here @tejveertradingzone
Yesterday 1:26 AM

On monday charges are to extended
😆😆
Trade here in APOLLOHOSP
1401.50🤩🤩🤩😍😍😍💵💵💵💵 #APOLLOHOSP

1402.10
500*2=1000/-🤩🤩🤩🤩💴💴💴💴💵💵💵🏆🏆🏆🏆 #APOLLOHOSP
Like
Reply
P
Reputation: 3,352 • Jul 3 5:51 AM

Apollohos cmp 1400-1398 buy intraday tgt 1415 positional tgt 1450 Sl 1377 #APOLLOHOSP
Like
Reply
Trade here in APOLLOHOSP
Target is yours and stop loss is yours 🏆🏆🏆💵💵💵💴...

1401.50🤩🤩🤩😍😍😍💵💵💵💵 #APOLLOHOSP
Like
Reply
Trade here in APOLLOHOSP
Target is yours and stop loss is yours 🏆🏆🏆💵💵💵💴...

Stop loss and target is only for paid subscribers.😍😍😍😍🤩🤩🤩🤩 #APOLLOHOSP
Like
Reply
Trade here in APOLLOHOSP
#APOLLOHOSP Above 1400 Buy 🤩🤩🤩💴💴💴🤩🤩🤩💵💵💵🏆🏆🏆

Target is yours and stop loss is yours
🏆🏆🏆💵💵💵💴💴💴 #APOLLOHOSP
Like
Reply

Above 1400
Buy
🤩🤩🤩💴💴💴🤩🤩🤩💵💵💵🏆🏆🏆
Like
Reply

Type
Sell
Instrument
APOLLOHOSP
Entry Price
₹1,384
Price@Trade
₹1,383.3
Target Price
₹1,368
Stop Price
₹1,395
Valid Till
Jul 10, 2020 3:20 AM
Margin
₹69,200 approx for 50 Qty
Status
Stoploss Hit
Exit Price
₹1,395
Net P&L
-₹550 (-0.79%)
Like
Reply (2)
Latest replies
TrackerBot @trackerbot
Jul 3 3:21 AM

Update
Trade Entered
Entry Price
₹1,384
TrackerBot @trackerbot
Jul 3 4:41 AM

Update
Stoploss Hit
Exit Price
₹1,395

Type
Sell
Instrument
APOLLOHOSP JUL20 FUT
Entry Price
₹1,355
Price@Trade
₹1,374.8
Target Price
₹1,343
Stop Price
₹1,367
Valid Till
Jul 3, 2020 3:20 AM
Margin
₹197,814 approx for 500 Qty
Status
Expired before entry
Like
Reply (1)
Latest replies
TrackerBot @trackerbot
Jul 3 8:50 AM

Update
Expired before entry
Price @ Update
₹1,384.35
S
Reputation: 1,770 • Jul 2 3:28 AM

Type
Buy
Instrument
APOLLOHOSP JUL20 1340 CE
Entry Price
₹73
Price@Trade
₹73
Target Price
₹110
Stop Price
₹39
Valid Till
Jul 30, 2020 3:20 AM
Margin
₹36,500 approx for 500 Qty
Status
Exited
Exit Price
₹75.7
Net P&L
+₹1,350 (+3.7%)
Like
Reply (1)
Latest replies
Santosh @santosh-Hyh2gPyPS
Jul 2 7:15 AM

Update
Exited
Exit Price
₹75.7
Net P&L
+₹1,350 (+3.7%)

Type
Buy
Instrument
APOLLOHOSP JUL20 FUT
Entry Price
₹1,357
Price@Trade
₹1,345
Target Price
₹1,380
Stop Price
₹1,344  ₹1,357.5
Valid Till
Jul 2, 2020 3:20 AM
Margin
₹192,352.5 approx for 500 Qty
Status
Stoploss Hit
Exit Price
₹1,357.5
Net P&L
+₹250 (+0.13%)
Like
Reply (3)
Latest replies
TrackerBot @trackerbot
Jul 2 4:04 AM

Update
Trade Entered
Entry Price
₹1,357
Money Matters @moneymatters
Jul 2 5:11 AM

Update
Stoploss Trailed
Price @ Update
₹1,358.5
Original SL
₹1,344
New SL
₹1,357.5
TrackerBot @trackerbot
Jul 2 5:13 AM

Update
Stoploss Hit
Exit Price
₹1,357.5
S
Reputation: 31 • Jul 2 2:57 AM

Type
Buy
Instrument
APOLLOHOSP JUL20 1400 CE
Entry Price
₹51.5
Price@Trade
₹50.35
Target Price
₹75
Stop Price
₹50
Valid Till
Jul 3, 2020 3:20 AM
Margin
₹25,750 approx for 500 Qty
Status
Stoploss Hit
Exit Price
₹50
Net P&L
-₹750 (-2.91%)
#APOLLOHOSP
Like
Reply (2)
Latest replies
TrackerBot @trackerbot
Jul 2 3:08 AM

Update
Trade Entered
Entry Price
₹51.5
TrackerBot @trackerbot
Jul 2 3:15 AM

Update
Stoploss Hit
Exit Price
₹50
R
Reputation: 39,811 • Jul 1 8:41 AM

Type
Buy
Instrument
APOLLOHOSP JUL20 FUT
Entry Price
₹1,320
Price@Trade
₹1,321.75
Target Price
₹1,345
Stop Price
₹1,315
Valid Till
Jul 2, 2020 3:20 AM
Margin
₹191,267 approx for 500 Qty
Status
Exited before entry
Like
Reply (1)
Latest replies
Rameswaran @rameswaran
Jul 2 3:12 AM

Update
Exited before entry
Price @ Update
₹1,346.8
T
Reputation: 16,924 • Jul 1 7:26 AM

Type
Buy
Instrument
APOLLOHOSP JUL20 FUT
Entry Price
₹1,313
Price@Trade
₹1,316.8
Target Price
₹1,355
Stop Price
₹1,275
Valid Till
Jul 30, 2020 3:20 AM
Margin
₹195,739 approx for 500 Qty
Status
Exited before entry
Like
Reply (2)
Latest replies
Tulasi @Tulasi9
Jul 1 7:26 AM

BTST
Tulasi @Tulasi9
Jul 1 8:45 AM

Update
Exited before entry
Price @ Update
₹1,322


APOLLOHOSP - EQ

Buy Above 1365.70 with SL Below 1334.30
For Tgts 1381.40 , 1397.10 , 1412.80

Sell Below 1334.30 with SL Above 1365.70
For Tgts 1318.60 , 1302.90 , 1287.20
Like
Reply (1)
Latest replies

ApolloHosp - Sell initiated & 1 tgt hit
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • APOLLOHOSP - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization16,985.86
    Enterprise Value19,761.2
    Price to Earnings63.45
    Price to Book Value4.37
    Return on Capital Employed0.09
    Return on Equity0.06
    Face Value5
    Dividend YieldNA
  • APOLLOHOSP - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    10-Dec-19ICICIdirect.comBuy1,800
    26-Jun-19Indiabulls VenturesBuy1,580
    31-May-19ICICIdirect.comBuy1,450
    12-Feb-19EdelweissBuy1,700
    11-Feb-19ICICIdirect.comBuy1,400
    APOLLOHOSP Brokerage Price Target
  • APOLLOHOSP Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Jul 31372140113661379.8
    Jul 213301367.91326.251362.55
    Jul 113501353.5513111319.65
    Jun 3013771384.4513441349.85
    Jun 2913811405.551359.251365.05
  • APOLLOHOSP Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹1,375.91
    30 Day Moving Average₹1,365.28
    50 Day Moving Average₹1,352.39
    100 Day Moving Average₹1,422.48
    200 Day Moving Average₹1,444.4
  • APOLLOHOSP - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue7,1836,441.770.12
    Operating Profit830774.010.07
    Profit Before Tax330358.92-0.08
    Net Income233285.15-0.18
  • APOLLOHOSP - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds3,8843,6940.05
    Total Liabilities4,5454,688-0.03
    Total Assets8,4288,3820.01
  • APOLLOHOSP - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity539623.51-0.14
    Cash from Investing Activity-378-817.62-0.54
    Cash from Financing Activity-106211.16-1.5
    Net Cash Flow5417.052.17
  • APOLLOHOSP - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.030.04
    Return on Equity0.060.08
    Return on Capital Employed0.090.09
  • APOLLOHOSP - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.56
    3 Year CAGR Growth in Operating Profit0.25
    3 Year CAGR Growth in EBIDTA0.19
    3 Year CAGR Growth in Net Income-0.33
    3 Yr CAGR Growth - Diluted EPS-0.33
  • APOLLOHOSP - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue1.16
    5 Year CAGR Growth in Operating Profit0.5
    5 Year CAGR Growth in EBIDTA0.43
    5 Year CAGR Growth in Net Income-0.25
    3 Yr CAGR Growth - Diluted EPS-0.25
  • APOLLOHOSP - Recent News

    keyboard_arrow_down
    NewsBot
    Jul 3 10:06 AM
    Apollo Hospitals Group's Proton Cancer Centre gets JCI accreditation
    The Economic Times
    NewsBot
    Jun 30 7:33 AM
    Sell Apollo Hospitals; target of Rs 1180: YES Securities
    Moneycontrol
    NewsBot
    Jun 30 6:11 AM
    Sell Apollo Hospitals, target price Rs 1,180: Yes Securities
    The Economic Times
    NewsBot
    Jun 29 11:01 AM
    For Apollo Hospitals, online pharmacy is the new growth frontier
    The Economic Times
    NewsBot
    Jun 29 4:13 AM
    Apollo Hospital Consolidated March 2020 Net Sales at Rs 2,922.43 crore, up 16.92% Y-o-Y
    Moneycontrol
    NewsBot
    Jun 29 4:03 AM
    Immunity booster for your portfolio! Here's a list of 10 stocks to get through COVID times
    Moneycontrol
    NewsBot
    Jun 29 3:43 AM
    Apollo Hospital Standalone March 2020 Net Sales at Rs 2,572.15 crore, up 18.69% Y-o-Y
    Moneycontrol
    NewsBot
    Jun 26 3:28 AM
    Apollo Hospitals gains as Q4 profit zooms 2-fold; Nomura retains buy
    Moneycontrol
    NewsBot
    Jun 25 4:48 AM
    Apollo Hospitals Enterprise Q4 net profit zooms over 2-fold to Rs 209.60 crore
    Moneycontrol
    NewsBot
    Jun 13 11:41 AM
    SAIL addresses the "unsubstantiated letter" regarding the demise of its Director and Covid management
    The Economic Times
  • APOLLOHOSP - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. NS...
    Aurobindo Pharma Ltd. NSE: AUROPHARMA...
    Cipla Ltd. NSE: CIPLA | BSE: 500087 |...
    Biocon Ltd. NSE: BIOCON | BSE: 532523...
    Lupin Ltd. NSE: LUPIN | BSE: 500257 |...
    Dr. Reddy's Laboratories Ltd. NSE: DR...
    Glenmark Pharmaceuticals Ltd. NSE: GL...
    Piramal Enterprises Ltd. NSE: PEL | B...
    Divi's Laboratories Ltd. NSE: DIVISLA...
    Cadila Healthcare Ltd. NSE: CADILAHC ...
  • APOLLOHOSP - More Information

    keyboard_arrow_down

    Apollo Hospitals Enterprises Ltd:
    Along with its subsidiaries, Apollo Hospitals Enterprise Limited has been providing healthcare services in India with an international venture. Primary, Secondary, and Tertiary care facilities are comprised of the company. Including cardiac sciences, oncology, critical care, neurosciences, orthopaedics, gastroenterology, and transplants tertiary care hospitals provide care in around 55 specialities. Along with this, the firm is providing different services, including project consultancy, health insurance, education and training program, and research services. Besides that pharmacies, primary care clinics, birthing centres, single-speciality clinics, primary health centres and diagnostic chains, dental clinics, and day-care and home healthcare centres operated by the firm. As of January 2019, the company started running 71 hospitals possessing 10,000 beds; 3,000 pharmacies. The company has 90 primary care and diagnostic clinics and approximately 110 telemedicine centres. Apollo Hospitals Enterprise Limited incepted in 1979 and has it headquarter in Chennai, India.
    Company Information:
    The company, seven years after its inception, added 46 beds in 1985. This group introduced the idea of developing corporate healthcare in India for the first time. Apollo introduced such hospitals which were providing the facility of Magnetic Resonance Imaging (MRI) even in the year of 1989, along with SOMATOMCR which is a Computed Tomography scanner for the entire body; Breast-scanning equipment such as Dideoendoscopy and Mammography were introduced too.
    In August 1991 The Apollo School of Nursing was founded, offering a 3-year diploma programme with an internship in the hospital. The hospital added 16 intensive care beds in 1992, along with developing its equipment in different departments. In 1993, Apollo Cancer Hospital, a premium cancer treatment and research centre, was established with 150-beds in Chennai. Along with that, it introduced the bone marrow transplant facility, developing its cancer project.
    Apollo Hospital Enterprise Limited (AHEL), developed a cancer hospital again in Hyderabad in 1995. In the same year, it was joined in the mission of eradicating Tuberculosis in India under WHO.
    Signing an MOU with Jardine of UK, AHEL adopted the health maintenance organisations (HMO) in 1997, a concept the nation witnessed for the first time. In the next year 1998, an MOU was signed between AHEL and Sri Lankan Government for building a super-speciality hospital in Colombo, which opened the door of AHEL’s international intervention.
    In 2002, the hospital captured the 50.26 % of in the Duncan Gleneagles Hospital against a minimal amount of Rs.3 crore. A tie-up with ICICI Lombard took place in 2003, introducing an accident insurance product. Developing a technology partnership with the Defence Research & Development Organisation (DRDO), AHEL enhanced its strength in 2004.
    Apollo Hospital Delhi was awarded a JCI certificate in 2005 for providing care in a safe environment. In June 2007, AHEL introduced Health City, for the first time in Asia, at Hyderabad with a holistic healthcare delivery facility, with an area of 33 acres mot only for treatment and research but also for hospitality management. In January 2008, an agreement took place between the hospital and the real estate firm Hindustan Construction Co (HCC), for launching a top-class medi-city inside the hill station Lavasa in Maharashtra.
    In June 2012, AHEL declared that International Finance Corporation (IFC) had requested the company for the transformation of the balance loan amount of US$ 7.50 million of Foreign Currency Convertible Bonds (FCCBs) into equity shares. Through making a primary equity infusion of Rs.450 crore, World Bank affiliated International Finance Corporation acquired a 29.03% stake in Apollo Health and Lifestyle Limited (AHLL), a subsidiary of the company, in the year of December 2016.
    Net profit of the company enhanced 28.57% to Rs.76.68 crore in the first quarter of 2019, ending in March against that of the previous quarter ended on March 2018 with Rs.59.64 crore. Similarly, the sales are enhanced by 16.30% to Rs.2167.11 crore in the first quarter of 2019 compared to the sales amount of Rs.1863.42 crore, that the company acquired in the first quarter of 2018.
    How Apollo Hospitals Enterprises Ltd, is categorised as Healthcare Sector, and Hospitals and Medical services Industry :
    Hospital and Medical Services Industry includes companies that are engaged in offering healthcare medical services and also operating standalone pharmacies. They offer services like hospitals, hospital-based pharmacies, consultancy services and projects. Some companies also provide health insurance services, research services and education and training programs.
    Apollo Hospitals Enterprises Ltd is categorized under the Health care sector and Hospitals and Medical services Industry. Healthcare sectors consist of firms involved in the medical space. It is one of the multiple sectors that comprise a range of businesses, including ones that offer medical services directly, or to those that work to develop, create and market medical equipment and medicines. It also includes the other services that provide medical insurance and other related products, and many more.
    The stocks of health care companies mostly have mixed performance. It is due to the inherent challenges to the industry each year, regulatory uncertainties, fiscal policy concerns, and more.
    Apollo Hospitals Enterprises Ltd, Competitors and Sector Peers:
    ADS Diagnostic Ltd. ADSDIA
    ANG Lifesciences India Ltd. ANGLIF
    Artemis Global Life Sciences Ltd. ARTGLO
    Aspira Pathlab & Diagnostics Ltd. ASPPAT
    Aster DM Healthcare Ltd. ASTDMH
    Birla Pacific Medspa Ltd. BIRPAC
    CDR Health Care Ltd. CDRHEA
    Chennai Meenakshi Multispeciality Hospital Ltd. DEVHOS
    Deccan Health Care Ltd. DECHEA
    Dhanvantri Jeevan Rekha Ltd. DHAJEE
    Dolphin Medical Services Ltd. DOLMED
    Dr. Agarwal's Eye Hospital Ltd. DRAGA
    Dr. Lal Pathlabs Ltd. DRLAL
    Dr. Lalchandani Labs Ltd. DRLALL
    Fortis Healthcare Ltd. FORHEA
    Fortis Malar Hospitals Ltd. MALHOS
    Healthcare Global Enterprises Ltd. HEAGLO
    Indo-Global Enterprises Ltd. INDOE
    Indraprastha Medical Corporation Ltd. INDRME
    Kids Medical Systems Ltd. KIDMED
    KMC Speciality Hospitals (India) Ltd. SEAHOS
    Kovai Medical Center and Hospital Ltd. KOVMED
    Looks Health Services Ltd. MONHEA
    Lotus Eye Hospital and Institute Ltd. LOTEYE
    Medinova Diagnostic Services Ltd. MEDDIA
    Metropolis Healthcare Ltd. METHEA
    N G Industries Ltd. NGINDL
    Narayana Hrudayalaya Ltd. NARHRU
    Noida Medicare Centre Ltd. NOIMED
    Regency Hospitals Ltd. REGHOS
    Sakar Healthcare Ltd. SAKHEA
    Scandent Imaging Ltd. PHACOM
    Secunderabad Healthcare Ltd. SECHEA
    Shalby Ltd. SHALLT
    Soni Medicare Ltd. SONMED
    STG Lifecare Ltd. STGTEC
    Tejnaksh Healthcare Ltd. TEJHEA
    Thyrocare Technologies Ltd. THYTEC
    Vimta Labs Ltd. VIMLAB
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.

PrivacyTerms
FrontPage © 2020